Sudarshan Pharma Says Proposed 9.5% Stake Acquisition in US Firm Under Due Diligence
New Delhi , September 15: Sudarshan Pharma Industries Ltd has provided an update on its proposed acquisition of a 9.5% equity stake in US-based Med Therapy Biotechnology Inc., stating that the transaction is currently under due diligence.…
Read More...
Read More...